SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-18-000667
Filing Date
2018-02-14
Accepted
2018-02-14 17:27:01
Documents
43
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_123117.htm 10-Q 429387
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 20186
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 18728
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 8772
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 8863
  Complete submission text file 0001387131-18-000667.txt   1853432

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20171231.xml EX-101.INS 200473
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20171231.xsd EX-101.SCH 20252
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20171231_cal.xml EX-101.CAL 31540
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20171231_def.xml EX-101.DEF 97707
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20171231_lab.xml EX-101.LAB 192788
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20171231_pre.xml EX-101.PRE 152186
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 18613897
SIC: 2834 Pharmaceutical Preparations